Author

Meng Dong

Dr. Margarete Fischer-Bosch-Institute of Clinical PharmacologyORCID 0000-0002-6434-1678Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Assay:ChIP-seq· 2 Research Focus:chromatin & epigenetic regulation· 2 Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Approach:statistical model· 2 Assay:ATAC-seq· 1

Frequent Co-Authors

Amro M. AbdelrahmaniD· 2 shared Julia ThieliD· 2 shared Mark Joseph TrutyiD· 2 shared Meghana ManjunathiD· 2 shared Nadine SchachereriD· 2 shared Steven A. JohnseniD· 2 shared Akshay KanakaniD· 1 shared Ashish Rajput· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Amro M. AbdelrahmanORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyScience AdvancesPeer-reviewedMar 18, 2026

KLF5 controls subtype-independent highly interactive enhancers in pancreatic cancer to regulate cell survival

Thomas L. Ekstrom, Zhangshuai Dai, Julia Thiel…·Steven A. Johnsen

This study identifies KLF5-bound enhancers in pancreatic cancer that regulate cell survival, showing their subtype-independent role in maintaining tumor viability.

2 citationstop 4%

humanATAC-seq

Cancer BiologyCell Death DiscoveryPeer-reviewedMar 17, 2026

Epigenetic Context Defines the Transcriptional Activity of Canonical and Noncanonical NF-κB Signaling in Pancreatic Cancer

Joana E. Aggrey-Fynn, Joshua Busch, Dominik Saul…·Steven A. Johnsen

This study identifies TNF and TWEAK as activators of canonical and noncanonical NF-κB signaling in PDAC, revealing distinct epigenetic dependencies of RELA and RELB.

1 citation

humanbulk RNA-seq

Cancer BiologybioRxivPreprintDec 7, 2025

IGFBPs define distinct pro-tumorigenic CAF subtypes in lung cancer tumour-microenvironment

Ghanapriya Yengkhom, Kunal Khemraj Nandgaonkar, Saikishore Ramanathan…·Sharathchandra Arandkar

The paper identifies IGFBP5, 6, and 7 as key regulators of CAF heterogeneity in lung cancer, showing their role in promoting tumour growth and cisplatin resistance.

DOI 10.64898/2025.12.03.692056

humanbulk RNA-seq